Filtration In Biopharmaceutical Development & Manufacturing

 

Pharmaceutical formulations, drug products, therapies, vaccines and the processes by which they are made are becoming increasingly diverse. Whether used for clarification or sterilization of final material, filtration remains an essential part of them.

 

In this presentation, Tom Watson talks about Pall’s range of filters including carbon removal filters, sterilizing grade filters (liquid and air/gas applications) and pre-filters for different types of drugs and manufacturing processes.

 

You will also understand how Pall Biotech is continuing to innovate in the field of prefiltration and sterilizing grade filtration in response to evolving regulatory standards and changes in drug classes.

 

Participants will learn about:

 

  • How to select a right filter for your product and process.
  • What’s new in the pre-filtration and sterilizing grade filtration.
  • Integrity testing of hydrophilic and hydrophobic filters.

Speaker

tom watson

Tom Watson

Global Product Manager, Sterilizing Grade Filters

Pall Biotech

 

Tom joined Pall in 2003, having graduated from the University of Sheffield, UK with a degree in Biotechnology and Microbiology. Following several years as an Account Manager, in 2010 he joined the Global Product Marketing first as Global Product Manager, Sterilizing-grade Filters and is now marketing group leader for Sterilizing grade filters, test instruments and systems.

Filtration In Biopharmaceutical Development & Manufacturing

icon image

Prepare for a Successful Validation of Liposome-Based Drugs

Download this guide to get recommendations for applying QbD principles for sterility assurance during aseptic processing

더 Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
March 2021
Case Study: Swissfillon’s Approach to Single-Use Formulation & Filling

Biotech | Pall Corporation 웨비나 시리즈

In 2019 Swissfillon were inspected and approved by the FDA to supply drug products into the USA, following on from EU approval in 2018. This young fill finish CMO was started in Switzerland in 2013 and built a state-of-the-art cGMP production facility from the ground up.

Swissfillon recognized early on that single-use systems met their requirements for multi-product manufacturing and would help their clients get their drugs to market faster.

During this case-study webinar, participants will learn:

  1. How working in partnership with a supplier can be part of a QbD approach to minimize risk
  2. Strategies & design improvements for single-use systems to reduce risk in the process
  3. How a shadowboard can be used to make single-use system leak tests, PUPSIT and the filtration process fast, safe and simple
등록